Bristol Myers Squibb Gross Margin Growth & History (BMY)

Bristol Myers Squibb's gross margin was 72.31% for fiscal 2020.

View full Bristol Myers Squibb company overview

Bristol Myers Squibb annual gross margin history

Bristol Myers Squibb annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20202020-12-3172.31%+3.21 pp
20192019-12-3169.10%−2.23 pp
20182018-12-3171.34%+0.67 pp
20172017-12-3170.67%−3.87 pp
20162016-12-3174.54%−1.85 pp
20152015-12-3176.39%+1.16 pp
20142014-12-3175.24%+3.43 pp
20132013-12-3171.81%−2.03 pp
20122012-12-3173.84%+0.19 pp
20112011-12-3173.65%+0.73 pp
20102010-12-3172.92%+0.25 pp
20092009-12-3172.67%

Bristol Myers Squibb gross margin trends

Over the last five reported fiscal years, Bristol Myers Squibb's gross margin decreased from 76.39% to 72.31%, a change of −4.08 percentage points.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Bristol Myers Squibb filings at SEC.gov ↗